BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ouwendijk WJ, Laing KJ, Verjans GM, Koelle DM. T-cell immunity to human alphaherpesviruses. Curr Opin Virol 2013;3:452-60. [PMID: 23664660 DOI: 10.1016/j.coviro.2013.04.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Peng Q, Guo X, Luo Y, Wang G, Zhong L, Zhu J, Li Y, Zeng X, Feng Z. Dynamic Immune Landscape and VZV-Specific T Cell Responses in Patients With Herpes Zoster and Postherpetic Neuralgia. Front Immunol 2022;13:887892. [PMID: 35720399 DOI: 10.3389/fimmu.2022.887892] [Reference Citation Analysis]
2 Heldman MR, Aagaard KM, Hill JA. Assessing and restoring adaptive immunity to HSV, VZV and HHV-6 in solid organ and hematopoietic cell transplant recipients. Clin Microbiol Infect 2022:S1198-743X(22)00057-X. [PMID: 35150885 DOI: 10.1016/j.cmi.2022.02.001] [Reference Citation Analysis]
3 Nalwoga A, Roshan R, Moore K, Marshall V, Miley W, Labo N, Nakibuule M, Cose S, Rochford R, Newton R, Whitby D. Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nat Commun 2021;12:7323. [PMID: 34916520 DOI: 10.1038/s41467-021-27623-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Ma F, Lf D, Ei T, Pa G. Herpes simplex virus interference with immunity: Focus on dendritic cells. Virulence 2021;12:2583-607. [PMID: 34895058 DOI: 10.1080/21505594.2021.1980990] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
5 Zhu S, Viejo-Borbolla A. Pathogenesis and virulence of herpes simplex virus. Virulence 2021;12:2670-702. [PMID: 34676800 DOI: 10.1080/21505594.2021.1982373] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
6 Reinert LS, Rashidi AS, Tran DN, Katzilieris-Petras G, Hvidt AK, Gohr M, Fruhwürth S, Bodda C, Thomsen MK, Vendelbo MH, Khan AR, Hansen B, Bergström P, Agholme L, Mogensen TH, Christensen MH, Nyengaard JR, Sen GC, Zetterberg H, Verjans GM, Paludan SR. Brain immune cells undergo cGAS/STING-dependent apoptosis during herpes simplex virus type 1 infection to limit type I IFN production. J Clin Invest 2021;131:136824. [PMID: 32990676 DOI: 10.1172/JCI136824] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
7 Katz J, Yue S, Xue W. Herpes simplex and herpes zoster viruses in COVID-19 patients. Ir J Med Sci 2021. [PMID: 34247308 DOI: 10.1007/s11845-021-02714-z] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
8 Xu R, Zhou Y, Cai L, Wang L, Han J, Yang X, Chen J, Chen J, Ma C, Shen L. Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19. Br J Dermatol 2020;183:1145-7. [PMID: 32790074 DOI: 10.1111/bjd.19484] [Cited by in Crossref: 20] [Cited by in F6Publishing: 39] [Article Influence: 10.0] [Reference Citation Analysis]
9 Martin MD, Badovinac VP, Griffith TS. CD4 T Cell Responses and the Sepsis-Induced Immunoparalysis State. Front Immunol 2020;11:1364. [PMID: 32733454 DOI: 10.3389/fimmu.2020.01364] [Cited by in Crossref: 9] [Cited by in F6Publishing: 27] [Article Influence: 4.5] [Reference Citation Analysis]
10 Harmon JR, Barbeau DJ, Nichol ST, Spiropoulou CF, McElroy AK. Rift Valley fever virus vaccination induces long-lived, antigen-specific human T cell responses. NPJ Vaccines 2020;5:17. [PMID: 32140261 DOI: 10.1038/s41541-020-0166-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
11 Huang R, Wu J, Zhou X, Jiang H, Guoying Zhou G, Roizman B. Herpes Simplex Virus 1 MicroRNA miR-H28 Exported to Uninfected Cells in Exosomes Restricts Cell-to-Cell Virus Spread by Inducing Gamma Interferon mRNA. J Virol 2019;93:e01005-19. [PMID: 31413129 DOI: 10.1128/JVI.01005-19] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
12 Truong NR, Smith JB, Sandgren KJ, Cunningham AL. Mechanisms of Immune Control of Mucosal HSV Infection: A Guide to Rational Vaccine Design. Front Immunol 2019;10:373. [PMID: 30894859 DOI: 10.3389/fimmu.2019.00373] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
13 Morris G, Maes M, Berk M, Puri BK. Myalgic encephalomyelitis or chronic fatigue syndrome: how could the illness develop? Metab Brain Dis 2019;34:385-415. [PMID: 30758706 DOI: 10.1007/s11011-019-0388-6] [Cited by in Crossref: 23] [Cited by in F6Publishing: 33] [Article Influence: 7.7] [Reference Citation Analysis]
14 Dendle C, Mulley WR, Holdsworth S. Can immune biomarkers predict infections in solid organ transplant recipients? A review of current evidence. Transplant Rev (Orlando) 2019;33:87-98. [PMID: 30551846 DOI: 10.1016/j.trre.2018.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
15 Levin MJ, Kroehl ME, Johnson MJ, Hammes A, Reinhold D, Lang N, Weinberg A. Th1 memory differentiates recombinant from live herpes zoster vaccines. J Clin Invest 2018;128:4429-40. [PMID: 30024861 DOI: 10.1172/JCI121484] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
16 Russell TA, Velusamy T, Tseng YY, Tscharke DC. Increasing antigen presentation on HSV-1-infected cells increases lesion size but does not alter neural infection or latency. J Gen Virol 2018;99:682-92. [PMID: 29620508 DOI: 10.1099/jgv.0.001059] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 De Groot-mijnes JDF, Chan ASY, Chee S, Verjans GMGM. Immunopathology of Virus-Induced Anterior Uveitis. Ocular Immunology and Inflammation 2018;26:338-46. [DOI: 10.1080/09273948.2018.1439069] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
18 Aravantinou M, Mizenina O, Calenda G, Kenney J, Frank I, Lifson JD, Szpara M, Jing L, Koelle DM, Teleshova N, Grasperge B, Blanchard J, Gettie A, Martinelli E, Derby N. Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques. Front Microbiol 2017;8:2342. [PMID: 29259582 DOI: 10.3389/fmicb.2017.02342] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
19 Meysman P, De Neuter N, Bartholomeus E, Elias G, Van den Bergh J, Emonds MP, Haasnoot GW, Heynderickx S, Wens J, Michels NR, Lambert J, Lion E, Claas FHJ, Goossens H, Smits E, Van Damme P, Van Tendeloo V, Beutels P, Suls A, Mortier G, Laukens K, Ogunjimi B. Increased herpes zoster risk associated with poor HLA-A immediate early 62 protein (IE62) affinity. Immunogenetics 2018;70:363-72. [PMID: 29196796 DOI: 10.1007/s00251-017-1047-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
20 Roshan R, Labo N, Trivett M, Miley W, Marshall V, Coren L, Cornejo Castro EM, Perez H, Holdridge B, Davis E, Matus-Nicodemos R, Ayala VI, Sowder R 2nd, Wyvill KM, Aleman K, Fennessey C, Lifson J, Polizzotto MN, Douek D, Keele B, Uldrick TS, Yarchoan R, Ohlen C, Ott D, Whitby D. T-cell responses to KSHV infection: a systematic approach. Oncotarget 2017;8:109402-16. [PMID: 29312617 DOI: 10.18632/oncotarget.22683] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
21 Wei L, Zhao J, Wu W, Zhang Y, Fu X, Chen L, Wang X. Decreased absolute numbers of CD3+ T cells and CD8+ T cells during aging in herpes zoster patients. Sci Rep 2017;7:15039. [PMID: 29118328 DOI: 10.1038/s41598-017-15390-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
22 Warren-Gash C, Forbes H, Breuer J. Varicella and herpes zoster vaccine development: lessons learned. Expert Rev Vaccines 2017;16:1191-201. [PMID: 29047317 DOI: 10.1080/14760584.2017.1394843] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
23 Scherer J, Enquist LW. Alphaherpesviruses: parasites of the peripheral nervous system. Future Virology 2017;12:555-9. [DOI: 10.2217/fvl-2017-0082] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Schiffer JT, Gottlieb SL. Biologic interactions between HSV-2 and HIV-1 and possible implications for HSV vaccine development. Vaccine 2019;37:7363-71. [PMID: 28958807 DOI: 10.1016/j.vaccine.2017.09.044] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
25 Halstead SB. Achieving safe, effective, and durable Zika virus vaccines: lessons from dengue. Lancet Infect Dis 2017;17:e378-82. [PMID: 28711586 DOI: 10.1016/S1473-3099(17)30362-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
26 Clementi N, Cappelletti F, Criscuolo E, Castelli M, Mancini N, Burioni R, Clementi M. Role and potential therapeutic use of antibodies against herpetic infections. Clinical Microbiology and Infection 2017;23:381-6. [DOI: 10.1016/j.cmi.2016.12.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
27 Posavad CM, Zhao L, Dong L, Jin L, Stevens CE, Magaret AS, Johnston C, Wald A, Zhu J, Corey L, Koelle DM. Enrichment of herpes simplex virus type 2 (HSV-2) reactive mucosal T cells in the human female genital tract. Mucosal Immunol 2017;10:1259-69. [PMID: 28051084 DOI: 10.1038/mi.2016.118] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
28 Qi Q, Cavanagh MM, Le Saux S, NamKoong H, Kim C, Turgano E, Liu Y, Wang C, Mackey S, Swan GE, Dekker CL, Olshen RA, Boyd SD, Weyand CM, Tian L, Goronzy JJ. Diversification of the antigen-specific T cell receptor repertoire after varicella zoster vaccination. Sci Transl Med 2016;8:332ra46. [PMID: 27030598 DOI: 10.1126/scitranslmed.aaf1725] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
29 Bender Ignacio RA, Ramchandani MS, Laing KJ, Johnston CM, Koelle DM. T Cell Immunity to Varicella-Zoster Virus in the Setting of Advanced HIV and Multiple Varicella-Zoster Virus Recurrences. Viral Immunol 2017;30:77-80. [PMID: 27870601 DOI: 10.1089/vim.2016.0097] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
30 Ma CK, Clancy L, Deo S, Blyth E, Micklethwaite KP, Gottlieb DJ. Herpes simplex virus type 1 (HSV-1) specific T-cell generation from HLA-A1- and HLA-A2-positive donors for adoptive immunotherapy. Cytotherapy 2017;19:107-18. [PMID: 27793552 DOI: 10.1016/j.jcyt.2016.09.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
31 Olp LN, Minhas V, Gondwe C, Poppe LK, Rogers AM, Kankasa C, West JT, Wood C. Longitudinal analysis of the humoral response to Kaposi's sarcoma-associated herpesvirus after primary infection in children. J Med Virol 2016;88:1973-81. [PMID: 27062052 DOI: 10.1002/jmv.24546] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
32 Kaufmann JK, Flechtner JB. Evolution of rational vaccine designs for genital herpes immunotherapy. Curr Opin Virol 2016;17:80-6. [PMID: 26896782 DOI: 10.1016/j.coviro.2016.01.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
33 Odegard JM, Flynn PA, Campbell DJ, Robbins SH, Dong L, Wang K, Ter Meulen J, Cohen JI, Koelle DM. A novel HSV-2 subunit vaccine induces GLA-dependent CD4 and CD8 T cell responses and protective immunity in mice and guinea pigs. Vaccine 2016;34:101-9. [PMID: 26571309 DOI: 10.1016/j.vaccine.2015.10.137] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
34 Laing KJ, Russell RM, Dong L, Schmid DS, Stern M, Magaret A, Haas JG, Johnston C, Wald A, Koelle DM. Zoster Vaccination Increases the Breadth of CD4+ T Cells Responsive to Varicella Zoster Virus. J Infect Dis 2015;212:1022-31. [PMID: 25784732 DOI: 10.1093/infdis/jiv164] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
35 Ouwendijk WJ, Verjans GM. Pathogenesis of varicelloviruses in primates. J Pathol 2015;235:298-311. [PMID: 25255989 DOI: 10.1002/path.4451] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
36 Çuburu N, Wang K, Goodman KN, Pang YY, Thompson CD, Lowy DR, Cohen JI, Schiller JT. Topical herpes simplex virus 2 (HSV-2) vaccination with human papillomavirus vectors expressing gB/gD ectodomains induces genital-tissue-resident memory CD8+ T cells and reduces genital disease and viral shedding after HSV-2 challenge. J Virol 2015;89:83-96. [PMID: 25320297 DOI: 10.1128/JVI.02380-14] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
37 Sicurella M, Nicoli F, Gallerani E, Volpi I, Berto E, Finessi V, Destro F, Manservigi R, Cafaro A, Ensoli B, Caputo A, Gavioli R, Marconi PC. An attenuated herpes simplex virus type 1 (HSV1) encoding the HIV-1 Tat protein protects mice from a deadly mucosal HSV1 challenge. PLoS One 2014;9:e100844. [PMID: 25033084 DOI: 10.1371/journal.pone.0100844] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
38 Salem Fourati I, Grenier AJ, Jolette É, Merindol N, Ovetchkine P, Soudeyns H. Development of an IFN-γ ELISpot assay to assess varicella-zoster virus-specific cell-mediated immunity following umbilical cord blood transplantation. J Vis Exp 2014. [PMID: 25046399 DOI: 10.3791/51643] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
39 Posavad CM, Zhao L, Mueller DE, Stevens CE, Huang ML, Wald A, Corey L. Persistence of mucosal T-cell responses to herpes simplex virus type 2 in the female genital tract. Mucosal Immunol 2015;8:115-26. [PMID: 24917455 DOI: 10.1038/mi.2014.47] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
40 Cabrera-Perez J, Condotta SA, Badovinac VP, Griffith TS. Impact of sepsis on CD4 T cell immunity. J Leukoc Biol 2014;96:767-77. [PMID: 24791959 DOI: 10.1189/jlb.5MR0114-067R] [Cited by in Crossref: 90] [Cited by in F6Publishing: 92] [Article Influence: 11.3] [Reference Citation Analysis]
41 Ouwendijk WJ, Geluk A, Smits SL, Getu S, Osterhaus AD, Verjans GM. Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells. J Immunol 2014;192:3730-9. [PMID: 24623134 DOI: 10.4049/jimmunol.1302307] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
42 Hsu M, Aravantinou M, Menon R, Seidor S, Goldman D, Kenney J, Derby N, Gettie A, Blanchard J, Piatak M Jr, Lifson JD, Fernández-Romero JA, Zydowsky TM, Robbiani M. A combination microbicide gel protects macaques against vaginal simian human immunodeficiency virus-reverse transcriptase infection, but only partially reduces herpes simplex virus-2 infection after a single high-dose cochallenge. AIDS Res Hum Retroviruses 2014;30:174-83. [PMID: 24117013 DOI: 10.1089/aid.2013.0165] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
43 van Velzen M, Jing L, Osterhaus AD, Sette A, Koelle DM, Verjans GM. Local CD4 and CD8 T-cell reactivity to HSV-1 antigens documents broad viral protein expression and immune competence in latently infected human trigeminal ganglia. PLoS Pathog 2013;9:e1003547. [PMID: 23966859 DOI: 10.1371/journal.ppat.1003547] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]